General Cannabis Valuation
| CANN Stock | USD 0.04 0 4.05% |
General Cannabis seems to be fairly valued based on Macroaxis valuation methodology. Our model calculates the value of General Cannabis Corp from evaluating the firm fundamentals such as Current Valuation of 35.32 M, return on equity of -0.73, and Return On Asset of -0.0299 as well as inspecting its technical indicators and probability of bankruptcy. . In general, most investors encourage obtaining undervalued assets and abandoning overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Fairly Valued
Today
Please note that General Cannabis' price fluctuation is out of control at this time. Calculation of the real value of General Cannabis Corp is based on 3 months time horizon. Increasing General Cannabis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the General otc stock is determined by what a typical buyer is willing to pay for full or partial control of General Cannabis Corp. Since General Cannabis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of General OTC Stock. However, General Cannabis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0355 | Real 0.0352 | Hype 0.04 | Naive 0.0342 |
The intrinsic value of General Cannabis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence General Cannabis' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of General Cannabis Corp helps investors to forecast how General otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of General Cannabis more accurately as focusing exclusively on General Cannabis' fundamentals will not take into account other important factors: General Cannabis Total Value Analysis
General Cannabis Corp is currently estimated to have valuation of 35.32 M with market capitalization of 18.61 M, debt of 5.91 M, and cash on hands of 1.07 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the General Cannabis fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
35.32 M | 18.61 M | 5.91 M | 1.07 M |
General Cannabis Investor Information
About 83.0% of the company shares are held by company insiders. The book value of General Cannabis was currently reported as 0.08. The company recorded a loss per share of 0.09. General Cannabis Corp had not issued any dividends in recent years. Based on the key indicators related to General Cannabis' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, General Cannabis Corp is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.General Cannabis Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. General Cannabis has an asset utilization ratio of 26.91 percent. This suggests that the OTC Stock is making $0.27 for each dollar of assets. An increasing asset utilization means that General Cannabis Corp is more efficient with each dollar of assets it utilizes for everyday operations.General Cannabis Ownership Allocation
General Cannabis Corp has a total of 114.17 Million outstanding shares. General Cannabis retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.81 (percent) of General Cannabis outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.General Cannabis Profitability Analysis
The company reported the previous year's revenue of 5.93 M. Net Loss for the year was (8.87 M) with profit before overhead, payroll, taxes, and interest of 1.49 M.About General Cannabis Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of General Cannabis Corp. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of General Cannabis Corp based exclusively on its fundamental and basic technical indicators. By analyzing General Cannabis's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of General Cannabis's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of General Cannabis. We calculate exposure to General Cannabis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of General Cannabis's related companies.Trees Corporation provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. Trees Corporation was incorporated in 2013 and is headquartered in Denver, Colorado. GENERAL CANNABIS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 77 people.
8 Steps to conduct General Cannabis' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates General Cannabis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct General Cannabis' valuation analysis, follow these 8 steps:- Gather financial information: Obtain General Cannabis' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine General Cannabis' revenue streams: Identify General Cannabis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research General Cannabis' industry and market trends, including the size of the market, growth rate, and competition.
- Establish General Cannabis' growth potential: Evaluate General Cannabis' management, business model, and growth potential.
- Determine General Cannabis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate General Cannabis' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
General Cannabis Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 89.6 M | |
| Retained Earnings | -83.8 M |
Other Information on Investing in General OTC Stock
General Cannabis financial ratios help investors to determine whether General OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in General with respect to the benefits of owning General Cannabis security.